Splenic cells from one BALB/c mouse and one C57/BL mouse, immunized with purified rat liver glucocorticoid receptor (GR), were fused with the mouse myeloma cell line Sp 2/0-Ag 14. Screening for production of anti-GRantibodies by the hybridomas was carried out with an enzymelinked immunosorbent assay, using partially purified rat liver GR as antigen. Further screening was by a second-antibody immunoprecipitation assay using [3H]triamcinolone acetonide-GR complex from rat liver cytosol as tracer. Hybridomas from 10 different microplate wells, positive in both assays, were successfully cloned by the limiting dilution method to monoclonality. The different origins of the monoclonal antibodies were confirmed by their various isoelectric points when analyzed by isoelectric focusing. Four of the monoclonal hybridoma cell lines secreted IgM antibodies; two, IgGl; three, IgG2a; and one, IgG2b. The GR-antibody complex was identified in glycerol density gradients by a shift of the 4S GR to an 8.5S or 19S GR-antibody complex when incubated with monoclonal IgG or IgM antibody, respectively. The 10 monoclonal antibodies recognized different determinants on the GR, all situated on that domain of the receptor that is separate from the ligand and DNA-binding domains. Also, the cross-reactivity to the mouse liver GR varied among the monoclonal antibodies. No cross-reactivity was observed to the human lymphocytic GR. NaDodSO4 electrophoresis of a 0.5% pure GR preparation followed by immunoblotting using one of the monoclonal antibodies identified a single peptide with a molecular weight of 94,000, identical to the purified rat liver GR.
Until recently, methods to study steroid receptor structure and mechanism of action have been dependent on the ability of the receptor protein to bind radiolabeled ligands. However, the glucocorticoid receptor (GR) has been reported to exist in an active and a nonactive form, respectively, in which only the former is capable of binding the ligand (1) . Furthermore, steroid receptors are sensitive proteins that under improper experimental conditions may lose their steroid binding capacity (2) . Using extensively purified steroid receptors, several groups have been able to raise antibodies against these proteins (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) and they have used the antibodies as tools to study receptor structure and function. Receptor antibodies make it possible to detect steroid receptors independently of their capacity to bind steroid. With regard to the GR, antibodies have been described by us (10, 12) and by others (13) (14) (15) (16) (17) . We have used polyclonal antibodies, raised in rabbits, immunized with highly purified rat liver cytosolic GR preparations, to characterize the structure of the GR (10) (11) (12) . With these antibodies, it was possible to characterize a non-ligand-binding domain of the GR that seems to be necessary for the biological function of the receptor (11) . However, fine structure analysis of steroid receptor molecules is limited by the heterogeneity and low titer of the polyclonal antisera. In this paper, we describe the preparation and properties of 10 monoclonal mouse antibodies against the rat liver GR.
MATERIALS AND METHODS
Immunization. GR (40-60% pure) was prepared from rat liver cytosol as described by Wrange et al. (18) , except that elution from the second DNA-cellulose column was carried out with 25 mM MgCl2. The amount of GR injected was estimated from radioactivity assuming one [3H]triamcinolone acetonide [TA, [9a-fluoro-11,B,21-dihydroxy-16a,17a-(1-methylethylidenebis[oxy])pregna-1 ,4-diene-3 ,20-dione]-binding site per receptor molecule and a calculated molecular weight of the GR of 94,000 (19) . GR was concentrated by trichloroacetic acid precipitation (20) and dissolved in 0.1-0.2 ml of phosphate-buffered saline (Pi/NaCl; 8 g of NaCl, 2.9 g of Na2HPO4 2H2O, 0.2 g of KH2PO4, and 0.2 g of KCl per liter, pH 7.4). For immunization, female BALB/c or C57/BL mice (Anticimex, Stockholm, Sweden), 8 weeks old, were used. The BALB/c mouse used for the fusion was immunized subcutaneously with 5 ug of GR emulsified in Freund's complete adjuvant (Difco). Booster injections were carried out 4 weeks later with 3 ,g of GR emulsified in Freund's incomplete adjuvant (Difco) given subcutaneously and after another 2 weeks with 4 gg of GR given intraperitoneally. The mouse was left for 2 months before the last booster injections, consisting of 8 and 7 ,g of GR, respectively, the latter including 25 ,g of colchicin (Sigma), were given intravenously with a 1-day interval. The spleen was removed for fusion 4 days after the last booster injection. The C57/BL mouse was treated according to a similar immunization protocol, although [3] [4] times higher doses of GR were given at each injection.
Cells and Media. The mouse myeloma cell line Sp 2/0-Ag 14 (21) was used as a fusion partner. This line was grown in Dulbecco's modified Eagle medium (DME medium) (Flow Laboratories). The medium was supplemented with 8% (vol/ vol) heat-inactivated fetal calf serum (FCS) (GIBCO, Biocult), bensylpenicillin (400 international units/ml; Astra, Sodertalje, Sweden), streptomycin (0.2 mg/ml; Novo, Copenhagen), 2 mM L-glutamine (Flow Laboratories), 1 mM sodium pyruvate (Flow Laboratories), bovine insulin (0.2 unit/ml; Sigma), oxaloacetic acid (0.15 mg/ml; Sigma), and 50 ,uM 2-mercaptoethanol (Sigma). DME medium was used after fusion with further addition of 0.1 mM hypoxanthine/0.2 AM aminopterin/1.6 mM thymidine (all from Sigma) (HAT medium). Feeder cells used were BALB/c macrophages, obtained by peritoneal lavage with 0.3 M sucrose. 
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Proc. NatL. Acad. Sci. USA 81 (1984) Fusion and Cloning. Fusion was carried out by the method of Kohler and Milstein (20, 22) , as modified by several authors (23) (24) (25) . A spleen/myeloma Sp 2/0 cells ratio of 5:1 and 1 ml of 50% (wt/vol) polyethylene glycol 4000 (Merck's for gas chromatography) was used. After fusion, 3 x 105 fused cells and 5 x 103 macrophages were added to each microwell in a total volume of 0.2 ml of HAT medium.
Monoclonal antibody-producing hybridomas were obtained by cloning the cells twice at limiting dilution on a feeder layer of 5 x 103 macrophages per well. Evaluation of the monoclonality of the hybridomas was carried out according to principles for limiting dilution (26) .
Large-scale production of monoclonal antibodies was carried out by growing hybridoma cells in culture or as ascites. Control ascites fluid was obtained in a similar way from Sp 2/0 cells. Isoelectric Focusing. Electrofocusing was carried out as described in LKB Instruction Manual 1818A (LKB Produkter, Bromma, Sweden). After completed focusing, the pH gradient was measured by using a surface pH electrode and this was immediately followed by immunofixation for 60 min at room temperature with rabbit anti-mouse immunoglobulin (Dako Immunoglobulins, Copenhagen), previously adsorbed on fetal calf serum coupled to CNBr-activated Sepharose 4B (Pharmacia) and diluted 1:15 in Pi/NaCl. After washing with Pi/NaCl, (three 40-min periods), the gel was covered with several layers of Whatman 3MM chromatography paper and pressed for 20 min with a 1-kg weight. On the gel was layered a solution of protein A (Pharmacia) in P1/NaCl for 45 min at room temperature. To the protein A was coupled horseradish peroxidase (Sigma) by the periodate method (27) , and then the gel was washed and pressed with filter paper as described above and stained with 3,3'-diaminobenzidine (0.3 mg/ml; Sigma)/0.005% H202 in 0.04 M Tris HCl (pH 7.6) for 20-30 min. The reaction was stopped by transferring the gel to water, and finally the gel was dried.
Test for Antibody Class. Class and subclass of the heavy chain of the monoclonal antibodies were determined by the Ouchterlony technique. Anti-mouse Ig class and subclass antisera-i.e., goat anti-IgM, -IgG1, -IgG2a, -IgG2b, and -IgA (Meloy Laboratories, Springfield, VA) and rabbit antiIgG3 (Litton Bionetics)-were used.
Enzyme-Linked Immunosorbent Assay (ELISA). Anti-GR antibodies in serum or in hybridoma culture medium were assayed by a direct ELISA using purified rat liver cytosolic GR (30-80% purity) attached to the ELISA microtiter wells. [3H]TA-labeled (specific activity, 31.3 or 37 Ci/mmol; 1 Ci = 37 GBq; New England Nuclear) cytosol was prepared in EPG buffer [20 mM sodium phosphate, pH 7.4/2 mM 2-mercaptoethanol/1 mM Na2EDTA/10% (wt/vol) glycerol] as described (10) . Limited proteolysis of the 6-nm rat liver GR to the 3.3-nm steroid-and DNA-binding GR fragment was carried out using a-chymotrypsin (28 Hybridomas from these eight wells were cloned (monoclonal antibodies 3-10) as described above.
Characterization of the monoclonal antibodies by isoelectric focusing in agarose gels ( Fig. 1) showed different isoelectric points for each of the 10 monoclonal antibodies. This shows that all 10 antibodies are different and that they originate from different stem cells.
Characterization of the monoclonal antibodies using classand subclass-specific anti-mouse immunoglobulins showed that four of the monoclonal antibodies were IgM, two were IgG1, three were IgG2a, and one was IgG2b ( Table 1) .
The titers (defined as the dilution of unpurified ascites that immunoprecipitated 50% of 0.1 pmol of rat liver cytosolic [3H]TA-GR complex in the second-antibody immunoprecipitation assay) of the monoclonal antibodies derived from ascites varied from 1:40 to 1:700 (Table 1 and Fig. 2 ). IgG antibodies occurred at higher titers compared with IgM antibodies (Table 1) .
Cross-reactivity and specificity of the monoclonal antibodies were tested by glycerol density gradient centrifugation in 0.15 M salt or by immunoprecipitation assay or both.
The 4S cytosolic [3H]TA-GR complex shifted to a sedimentation coefficient of 8.5 S when incubated with any of monoclonal IgG antibodies [5] [6] [7] [8] [9] (Fig. 3) [H]TA-GR-antibody complex when incubated with one of monoclonal IgM antibodies [1] [2] [3] [4] (Fig. 4) , and combination of two monoclonal IgM antibodies gave an additional displacement of the sedimentation peak to about 24 S (Fig. 4) . This suggests that the monoclonal IgM antibodies recognize different antigenic determinants on the receptor molecule.
The 6-nm rat liver GR can be reso'lved into three domains-a steroid-bindin'g domain, a DNA-binding domain, and a domain that also seems to be necessary for the biological function of the GR (11, 32) . Seven of seven of our polyclonal rabbit antisera tested bound to the latter domain but not to the other two GR domains (12 [3H]TA-GR complex (0.1 pmol) from crude rat liver cytosol was incubated with 250 ,ul of control ascites, Sp 2/0 (x), 30 (wt/vol) glycerol density gradients and centrifuged as described in Fig. 3. bind to the 3.3-nm steroid-and DNA-binding entity (data not shown). None of the monoclonal antibodies showed any cross-reactivity to the human lymphocytic GR. However, 4 of 9 monoclonal antibodies tested showed cross-reactivity to the mouse liver GR (Table 1) . No difference in antibody reactivity to rat liver as compared with rat lung GR was seen for either monoclonal antibodies 1 or 2. Furthermore, monoclonal antibody 1 did not cross-react with the estrogen or progestin receptor from rat uterus (data not shown). The monoclonal antibodies of IgG2a class bound Staphylococcus aureus protein A ( Table 1) .
The immunoblotting technique (33) was used to test the monospecificity of the monoclonal antibodies. A 50% pure GR preparation (Fig. 5A, lane 1 ) and a parallel sample to which 100 times the amount of cytosolic protein was added (final degree of receptor purity, 0.5%; Fig. 5A , lane 2) were separated by NaDodSO4/PAGE (36) . Parallel preparations were analyzed by immunoblotting using monoclonal antibody 7 (Fig. 5B, lanes 1 and 2) (37) . When analyzed by isoelectric focusing, all monoclonal antibodies except no. 10 showed fewer than three or four bands on the gel (Fig. 1) (10) (11) (12) and by Eisen and coworkers (38) . Also, the monoclonal antibodies against the rat liver GR, recently described by Westphal et al. (17) , showed the same specificity. However, Govindan and Sekeris (13) have raised polyclonal antibodies that also recognize the steroid-and DNA-binding GR entity (cf. above). This discrepancy may perhaps be explained by different purification or immunization techniques.
Some of the monoclonal antibodies described in this paper cross-reacted with the mouse liver GR but none bound to the human lymphocytic GR, suggesting that some antigenic determinants are highly species specific. Westphal et al. (17) found that only one out of eight monoclonal anti-rat GR antibodies recognized GR from other species. Similar observations were made by Greene et al. (5), who raised monoclonal antibodies against the estrogen receptor from calf uterus. They found no cross-reactivity to estrogen receptor from several other species tested. However, their monoclonal antibodies to the human estrogen receptor cross-reacted with estrogen receptor from several other mammalian species (6) . In contrast to this, some monoclonal antibodies raised against the calf uterus estrogen receptor by Moncharmont et al. (7) cross-reacted with the human receptor. 
